A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Artivion, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 143,964 shares of AORT stock, worth $3.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
143,964
Previous 68,804 109.24%
Holding current value
$3.84 Million
Previous $1.76 Million 117.23%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$24.33 - $28.46 $1.83 Million - $2.14 Million
75,160 Added 109.24%
143,964 $3.83 Million
Q2 2024

Aug 14, 2024

BUY
$19.62 - $25.65 $1.35 Million - $1.76 Million
68,804 New
68,804 $1.76 Million
Q4 2023

Feb 14, 2024

BUY
$12.33 - $18.83 $575,897 - $879,492
46,707 Added 138.98%
80,313 $1.44 Million
Q3 2023

Nov 15, 2023

BUY
$14.82 - $17.52 $498,040 - $588,777
33,606 New
33,606 $509,000
Q4 2022

Feb 14, 2023

SELL
$10.01 - $13.9 $292,241 - $405,810
-29,195 Reduced 48.22%
31,349 $380,000
Q3 2022

Nov 14, 2022

BUY
$13.31 - $23.25 $49,606 - $86,652
3,727 Added 6.56%
60,544 $838,000
Q2 2022

Aug 15, 2022

BUY
$15.73 - $22.91 $218,678 - $318,494
13,902 Added 32.39%
56,817 $1.07 Million
Q1 2022

May 16, 2022

SELL
$16.95 - $21.74 $196,959 - $252,618
-11,620 Reduced 21.31%
42,915 $918,000
Q4 2021

Feb 14, 2022

BUY
$17.19 - $22.84 $219,361 - $291,461
12,761 Added 30.55%
54,535 $1.11 Million
Q3 2021

Nov 15, 2021

BUY
$22.29 - $28.7 $931,142 - $1.2 Million
41,774 New
41,774 $931,000
Q1 2021

May 17, 2021

SELL
$22.07 - $26.31 $391,676 - $466,923
-17,747 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$16.76 - $23.74 $221,232 - $313,368
-13,200 Reduced 42.65%
17,747 $419,000
Q3 2020

Nov 16, 2020

BUY
$16.35 - $21.4 $505,983 - $662,265
30,947 New
30,947 $572,000

Others Institutions Holding AORT

About ARTIVION, INC.


  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $1.08B
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.